Evidence map›Paper›PMID 42430157›Full record

ArticleJAMA health forum2026

Primary Care Cost Sharing in Medicare Advantage.

Changchuan Jiang, Chuan Angel Lu, Lesi He, Arthur S Hong, Xin Hu, Megan Mullins, Boshen Jiao, Joshua M Liao

Abstract read
In one paragraph

Article in JAMA health forum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Changchuan JiangDivision of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas.
Chuan Angel LuDivision of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas.
Lesi HeDepartment of Health Data Science and Biostatistics, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas.
Arthur S HongDepartment of Health Data Science and Biostatistics, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas.
Xin HuDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, Georgia.
Megan MullinsDepartment of Health Data Science and Biostatistics, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas.
Boshen JiaoLeonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles.
Joshua M LiaoDepartment of Health Data Science and Biostatistics, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Medicare Advantage (MA) plans increasingly leverage cost-sharing structure to incentivize high-value care utilization, yet national adoption and distribution of $0 cost sharing for in-network primary care physician (PCP) visits remain poorly characterized. Objective: To examine longitudinal trends and plan- and county-level characteristics of $0 cost sharing for in-network PCP visits among MA plans. Design, Setting, and Participants: This cross-sectional study involved a retrospective ecological analysis of MA plan-county observations, including general enrollment MA plans (health maintenance organization, preferred provider organization, and health maintenance organization point-of-service plans) offered across US counties from 2019 to 2025. Data were analyzed from December 2025 to March 2026. Exposures: Plan-level characteristics (plan type, premium status, geographic region, and Centers for Medicare & Medicaid Services star rating) and county-level characteristics (MA penetration, urbanicity, federal poverty level, racial and ethnic composition, and PCP accessibility). Main Outcomes and Measures: The primary outcome was the enrollment trend in MA plans offering $0 cost sharing for in-network PCP visits from 2019 to 2025. Secondary outcomes included plan- and county-level factors associated with offering this benefit in 2025, estimated using multivariable mixed-effects logistic regression with county-level random intercepts. Results: The proportion of MA beneficiaries enrolled in plans requiring no cost sharing for in-network PCP visits increased from 46.4% in 2019 to 78.1% in 2025 (P for trend < .001), equating to approximately 15 million additional beneficiaries. In 2025, plans offering this benefit were more likely preferred provider organization plans than health maintenance organization plans (adjusted odds ratio [AOR], 2.14; 95% CI, 2.05-2.23) and featured better performances (5-star rating: AOR, 6.71; 95% CI, 4.83-9.32). Geographically, plans offering this benefit were more prevalent in urbanized counties (AOR, 1.17; 95% CI, 1.11-1.24), had higher MA penetration (AOR, 1.31; 95% CI, 1.22-1.40, and had larger proportions of racial and ethnic minority populations (AOR, 1.18; 95% CI, 1.09-1.28). In contrast, zero-premium plans (AOR, 0.70; 95% CI, 0.68-0.73) and plans offered in high-poverty counties (AOR, 0.82; 95% CI, 0.74-0.90) showed considerably lower availability of $0 cost sharing. Conclusions and Relevance: This cross-sectional study demonstrates that $0 cost sharing for PCP visits has expanded rapidly under MA but remains unevenly distributed. Lower availability in zero-premium plans and high-poverty areas suggest strategic trade-offs between premiums and point-of-service costs, raising equity concerns that underscore the need to assess whether market-driven benefit design optimizes and sustains high-value primary care access to counties at greater populational health risk.

Indexed as

Cost SharingMedicare Part CPrimary Health CareCross-Sectional StudiesHealth Maintenance OrganizationsHumansRetrospective StudiesUnited States

Identifiers

PMID42430157
PMCPMC13355145

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.